100.0% 88.24 20.8% Cost of sa les (271.69) -53.1% (249.07) -58.8% 22.62 9.1% Gross profit 240.44 46.9% 174.81 41.2% 65.63 37.5% Other income 3.51 0.7% 2.29 0.5% 1.22 53.3% Distribution costs (102.59

million to Baht 66.59 million in 2019 or increased by 37.1%.  Distribution costs for the 2nd quarter 2019 represented 21.0% of revenue from sales while in 2018 was at 20.7% of revenue from sale, increased

truck. As a result, the company has income from rental change and income from the sale of assets from the restructuring, the total amount about 17 million baht. Consolidated Financial Statement for Group

last year which came from more effective management in logistic & distribution. Statements of Financial Position and Selling and Administrative expenses Financial cost Unit : THB million Change Y2019

Summary of operations and the factors that make a significant change Summary of Operations for the Year 2023 Operation Overview Annual Balance Change 2023 2022 2023 VS 2022 Million baht (MB) (MB) % Total

granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change

market in the country last April. This caused problems for distribution channels of the Company’s customers, as they had to postpone their purchase orders of the Company’s products. As result, domestic

-2022 Balance by Quarter Change Topic Q2-22 Q1-22 Q2-21 Q1-22 VS Q1-22 Q2-22 VS Q2-21 (Million Baht: MB) (MB) % (MB) % Total revenue 1,711.8 1,399.2 2,081.2 312.6 22.3 (369.4) (17.7) Total operating

hospital operations in the amount of Baht 193.9 million or 15.5%. Distribution cost and administrative expenses increased in the amount of Baht 33.9 million or 13.3% which in line with the increased revenue

: Unit: Million Baht Revenue Structure Q2/2019 Q2/2018 Change General Patient Revenue 1,384.2 1,284.6 99.6 7.8% Social Security Scheme Revenue 752.8 633.3 119.5 18.9% Other Revenue 30.0 27.3 2.7 9.9% Total